NNS 2026

John Gensel, Dr.

Director

All Sessions by John Gensel, Dr.

4:00 pm - 4:20 pm

S07.02 - The Macrophage Contribution to Secondary Injury: Cell Origin and Heterogeneity in Spinal Cord Injury Pathophysiology

5:15 pm - 7:00 pm

POB.148 - Transcriptional Profiling of Spinal Cord Macrophages Following Treatment with LPS-MSC-Derived Nanovesicles

4:30 pm - 6:30 pm

POA.51 - Serum Biomarker Diagnostic and Prognostic Efficacy in Human Degenerative Cervical Myelopathy Patients